Trials / Terminated
TerminatedNCT03118479
Effect of Varying Testosterone Levels on Insulin Sensitivity in Men With Idiopathic Hypogonadotropic Hypogonadism (IHH)
Effect of Varying Testosterone Levels on Insulin Sensitivity in Men With Idiopathic Hypogonadotropic Hypogonadism
- Status
- Terminated
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 7 (actual)
- Sponsor
- Massachusetts General Hospital · Academic / Other
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The investigators are doing this research study to look at the relationship between testosterone (the main sex hormone in men) and insulin (the hormone that controls blood sugar levels) in men with Idiopathic Hypogonadotropic Hypogonadism (IHH). The investigators hypothesize that normalizing testosterone levels in men with IHH enhances insulin sensitivity, reduces visceral fat, increases lean body mass, and improves the lipid profile.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Anastrozole Pill | 10 mg of Anastrozole to be taken daily for 3 months. |
| DRUG | Testosterone | Androgel 7.5 g to be applied transdermally daily for 3 months. |
| DRUG | Placebo Oral Tablet | One tablet to be taken daily for 3 months |
Timeline
- Start date
- 2010-05-01
- Primary completion
- 2010-09-01
- Completion
- 2010-09-01
- First posted
- 2017-04-18
- Last updated
- 2017-04-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03118479. Inclusion in this directory is not an endorsement.